--- title: "美國股市在波動中表現不一，原油價格回升" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/278613776.md" description: "美國股市在波動中表現不一，原油價格在早前下跌後反彈。現有住宅銷售增長了 1.7%，年化銷售率達到 409 萬套，超出預期。福泰製藥的股票因其腎病治療的積極試驗結果上漲了 8.5%。相比之下，康西哥的股票因首席執行官 Sarah London 在一次醫療會議上提到預計在《平價醫療法案》市場中面臨的挑戰而下跌了 16%" datetime: "2026-03-10T20:22:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278613776.md) - [en](https://longbridge.com/en/news/278613776.md) - [zh-HK](https://longbridge.com/zh-HK/news/278613776.md) --- # 美國股市在波動中表現不一，原油價格回升 04:22 PM EDT, 03/10/2026 (MT Newswires) -- US equity indexes were mixed Tuesday amid volatile trading after crude oil prices moved up after falling earlier in the day. \* US existing home sales rose 1.7% sequentially to a seasonally adjusted annual rate of 4.09 million units last month, compared with an anticipated 0.8% decline, according to a Bloomberg-compiled survey. \* April West Texas Intermediate crude oil fell $8.51 to settle at $86.26 per barrel, while May Brent crude, the global benchmark, was last seen up $7.92 at $91.02. \* Vertex Pharmaceuticals ( VRTX ) said a prespecified week 36 interim analysis of its ongoing phase 3 trial of povetacicept in immunoglobulin A nephropathy, a kidney disease, showed favorable results. Shares of the company were up nearly 8.5%, the biggest gainer on the S&P 500 and Nasdaq. \* Centene Corporation ( CNC ) shares were down roughly 16% after the company said it expects continuing headwinds in its operations in the Affordable Care Act marketplace, multiple media outlets reported, citing CEO Sarah London's presentation at the Barclays 28th Annual Global Healthcare Conference. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相關股票 - [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [IHE.US](https://longbridge.com/zh-HK/quote/IHE.US.md) - [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md) - [VRTX.US](https://longbridge.com/zh-HK/quote/VRTX.US.md) - [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md) - [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [VHT.US](https://longbridge.com/zh-HK/quote/VHT.US.md) - [IXJ.US](https://longbridge.com/zh-HK/quote/IXJ.US.md) - [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md) - [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md) - [XLV.US](https://longbridge.com/zh-HK/quote/XLV.US.md) - [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md) - [CNC.US](https://longbridge.com/zh-HK/quote/CNC.US.md) - [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md) ## 相關資訊與研究 - [巨生醫細胞治療產品獲 SelectUSA Tech 醫療領域前 8 強 有助美國市場佈局](https://longbridge.com/zh-HK/news/282988767.md) - [巨生醫細胞治療產品 MPB-2354 獲選 SelectUSA Tech 醫療領域前八強](https://longbridge.com/zh-HK/news/282972944.md) - [Intensity Therapeutics 因其在醫療創新領域的卓越表現而榮獲巔峯獎 | INTS 股票新聞](https://longbridge.com/zh-HK/news/282852587.md) - [鉅亨速報 - Factset 最新調查：Summit Therapeutics Inc(SMMT-US) EPS 預估上修至-1.2 元，預估目標價為 33.00 元](https://longbridge.com/zh-HK/news/282998825.md) - [恆瑞醫藥注射用 SHR-A2102 獲納入突破性治療品種名單，適應症涉宮頸癌](https://longbridge.com/zh-HK/news/283069796.md)